-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2025-521398-15-00
5
2025-12-04
Immune system diseases
-
2025-521381-10-00
5
2025-12-03
Moderately to Severely Active Ulcerative Colitis
-
2024-512849-17-00
5
2025-11-14
Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Di
-
2024-520409-38-00
1
2025-11-14
Eosinophilic esophagitis (EoE)
-
2025-520555-89-00
5
2025-11-14
Metastatic castration-resistant prostate cancer (mCRPC)
-
2024-518008-33-00
5
2025-11-12
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2025-521260-35-00
6
2025-11-07
acute ischemic stroke and atrial fibrillation (AF)
-
2024-520290-12-00
6
2025-11-04
Hormone receptor–positive (HRpos)/human epidermal growth factor recept
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2023-506296-97-00
5
2025-10-28
Moderate to Severe Plaque Psoriasis
-
2025-520564-17-00
5
2025-10-16
Hidradenitis suppurativa (HS)
-
2024-520264-33-00
5
2025-10-07
Locoregionally recurrent head and neck squamous cell carcinoma (HNSCC)
-
2024-517632-22-00
5
2025-10-06
Hidradenitis Suppurativa
-
2025-521497-34-00
1
2025-10-06
Neuroblastoma
-
2023-509861-19-01
4
2025-09-30
High-grade B-cell lymphoma (HGBL)
-
2024-514504-13-00
4
2025-09-23
psoriatic arthritis
-
2024-517190-24-00
4
2025-09-16
Peritoneal Cancer
-
2024-513171-41-00
5
2025-09-11
Vitiligo
-
2024-518325-15-00
5
2025-09-08
Gastroenteropancreatic neuroendocrine tumor (GEP-NET)
-
2024-519532-16-00
9
2025-07-30
Idiopathic inflammatory myositis